LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

ABSTRACT: Phase I trial to study the effectiveness of LMB-9 immunotoxin in treating patients who have advanced colon, breast, non-small cell lung, bladder, pancreatic, or ovarian cancer. The LMB-9 immunotoxin can locate tumor cells and kill them without harming normal cells.

DISEASE(S): Ovarian Cancer,Lung Cancer,Carcinoma, Ovarian Epithelial,Colorectal Cancer,Urinary Bladder Neoplasms,Bladder Cancer,Pancreatic Cancer,Ovarian Neoplasms,Breast Neoplasms,Pancreatic Neoplasms,Breast Cancer,Lung Neoplasms

PROVIDER: 2004933 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR